CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 187 filers reported holding CRISPR THERAPEUTICS AG in Q3 2018. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $609,000 | +48.5% | 10,000 | 0.0% | 0.41% | +31.4% |
Q3 2019 | $410,000 | -13.0% | 10,000 | 0.0% | 0.32% | -2.8% |
Q2 2019 | $471,000 | +31.9% | 10,000 | 0.0% | 0.32% | +27.1% |
Q1 2019 | $357,000 | +24.8% | 10,000 | 0.0% | 0.26% | +0.4% |
Q4 2018 | $286,000 | -35.6% | 10,000 | 0.0% | 0.25% | -12.4% |
Q3 2018 | $444,000 | -24.5% | 10,000 | 0.0% | 0.29% | -30.5% |
Q2 2018 | $588,000 | +28.7% | 10,000 | 0.0% | 0.42% | +20.2% |
Q1 2018 | $457,000 | -35.1% | 10,000 | -66.7% | 0.35% | -37.4% |
Q4 2017 | $704,000 | – | 30,000 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |